DE60307082D1 - PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE - Google Patents
PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVEInfo
- Publication number
- DE60307082D1 DE60307082D1 DE60307082A DE60307082A DE60307082D1 DE 60307082 D1 DE60307082 D1 DE 60307082D1 DE 60307082 A DE60307082 A DE 60307082A DE 60307082 A DE60307082 A DE 60307082A DE 60307082 D1 DE60307082 D1 DE 60307082D1
- Authority
- DE
- Germany
- Prior art keywords
- desmopressin
- dispersible
- pharmaceutical composition
- mouth valve
- mouth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0210397.6A GB0210397D0 (en) | 2002-05-07 | 2002-05-07 | Pharmaceutical formulations |
PCT/IB2002/004036 WO2003094885A1 (en) | 2002-05-07 | 2002-09-20 | Sublingual pharmaceutical formulation of desmopressin |
PCT/IB2003/002368 WO2003094886A2 (en) | 2002-05-07 | 2003-05-07 | Desmopressin in an orodispersible dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60307082D1 true DE60307082D1 (en) | 2006-09-07 |
Family
ID=29422105
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2003607082 Expired - Lifetime DE60307082T4 (en) | 2002-05-07 | 2003-05-07 | PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE |
DE60307082A Expired - Lifetime DE60307082D1 (en) | 2002-05-07 | 2003-05-07 | PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2003607082 Expired - Lifetime DE60307082T4 (en) | 2002-05-07 | 2003-05-07 | PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE |
Country Status (10)
Country | Link |
---|---|
JP (1) | JP2006502972A (en) |
AU (1) | AU2003233118B8 (en) |
BR (1) | BR0309819A (en) |
CA (1) | CA2484724C (en) |
DE (2) | DE60307082T4 (en) |
HR (1) | HRP20041152B1 (en) |
NO (1) | NO335167B1 (en) |
NZ (1) | NZ535861A (en) |
PT (1) | PT1501534E (en) |
WO (1) | WO2003094886A2 (en) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
JP4523265B2 (en) * | 2002-11-13 | 2010-08-11 | 旭化成ファーマ株式会社 | Orally disintegrating preparations for the treatment of urination disorders |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US7094545B2 (en) | 2003-04-30 | 2006-08-22 | Ferring Bv | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
PT1500390E (en) | 2003-07-25 | 2005-10-31 | Ferring Bv | PHARMACEUTICAL COMPOSITION AS A SOLID DOSAGE FORM AND METHOD OF PRODUCTION |
CN1878563A (en) * | 2003-11-10 | 2006-12-13 | 西摩·H·费恩 | Pharmaceutical compositions including low dosages of desmopressin |
DK1530967T3 (en) | 2003-11-13 | 2006-07-03 | Ferring Bv | Blister pack and associated solid dosage form |
CA2490601C (en) * | 2003-12-29 | 2006-05-02 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
PT1550439E (en) * | 2003-12-29 | 2006-06-30 | Ferring Bv | METHOD FOR PREPARING A SOLID FORM OF DESMOPRESSIN DOSAGE |
US7018653B2 (en) | 2003-12-29 | 2006-03-28 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
GB0406048D0 (en) * | 2004-03-18 | 2004-04-21 | Ardana Bioscience Ltd | Drug formulations |
US7972621B2 (en) * | 2004-06-03 | 2011-07-05 | R.P. Scherer Technologies, Llc | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
CA2584456C (en) * | 2006-03-02 | 2008-07-22 | Ferring International Center S.A. | Composition comprising desmopressin |
SE528446C2 (en) * | 2006-03-02 | 2006-11-14 | Ferring Int Ct Sa | Pharmaceutical composition comprising desmopressin, silica and starch |
ES2382982T3 (en) | 2007-07-21 | 2012-06-15 | Albany Molecular Research, Inc. | Indazoles substituted with 5-pyridinone and pharmaceutical compositions thereof |
US8399410B2 (en) | 2007-08-06 | 2013-03-19 | Allergan, Inc. | Methods and devices for desmopressin drug delivery |
EP2674417A3 (en) | 2007-11-21 | 2014-04-09 | Decode Genetics EHF | Biaryl PDE4 inhibitors for treating inflammation |
EP2240481A1 (en) | 2008-01-11 | 2010-10-20 | Albany Molecular Research, Inc. | (1-azinone) -substituted pyridoindoles as mch antagonists |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
LT3225249T (en) * | 2008-05-21 | 2019-01-10 | Ferring B.V. | Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia |
WO2010059836A1 (en) | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Substituted aza-bridged bicyclics for cardiovascular and cns disease |
KR101675174B1 (en) | 2009-01-26 | 2016-11-10 | 이스라엘 인스티튜트 포 바이올로지컬 리서치 | Bicyclic heterocyclic spiro compounds |
TWI471127B (en) | 2009-04-29 | 2015-02-01 | Intervet Int Bv | A process for preparing an orally disintegrating tablet for human use, an orally disintegrating tablet thus obtained and a package containing the orally disintegrating tablet |
TWI468157B (en) * | 2009-04-29 | 2015-01-11 | Intervet Int Bv | Process to form a tablet, system for performing this process and package comprising the tablet |
ES2929471T3 (en) | 2009-06-18 | 2022-11-29 | Acerus Pharmaceuticals Usa Llc | Safe administration of desmopressin |
MX2012000572A (en) | 2009-07-14 | 2012-05-08 | Albany Molecular Res Inc | 5-ht3 receptor modulators, methods of making, and use thereof. |
US10548839B2 (en) | 2010-03-16 | 2020-02-04 | Wei Tian | Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |
JP5736031B2 (en) | 2010-03-29 | 2015-06-17 | フェリング ベスローテン フェンノートシャップ | Fast-dissolving pharmaceutical composition |
JO3112B1 (en) | 2010-03-29 | 2017-09-20 | Ferring Bv | A fast dissolving pharmaceutical composition |
BR112013009255B1 (en) * | 2010-10-08 | 2021-02-23 | R.P. Scherer Technologies, Llc | solid composition of rapid dissolving oral vaccine |
JP2011116764A (en) * | 2011-02-08 | 2011-06-16 | Fine Seymour H | Medical composition containing low dose desmopressin |
JP6174585B2 (en) | 2011-09-16 | 2017-08-02 | フェリング ベスローテン フェンノートシャップ | Fast dissolving pharmaceutical composition |
JP5928159B2 (en) * | 2012-05-28 | 2016-06-01 | ニプロ株式会社 | Pharmaceutical composition |
TW201422254A (en) * | 2012-11-21 | 2014-06-16 | Ferring Bv | Composition for immediate and extended release |
CN103993061B (en) * | 2014-05-20 | 2018-03-23 | 海南美合泰生物科技有限公司 | A kind of production method of Isin glue collagen |
KR20150144209A (en) * | 2014-06-16 | 2015-12-24 | 훼링 비.브이. | Pharmaceutical composition comprising stabilized desmopressin or pharmaceutically acceptable salt thereof |
JP6341777B2 (en) * | 2014-06-30 | 2018-06-13 | リプリーズ バイオファーマシューティクス,エルエルシー | Pharmaceutical composition containing low dose desmopressin |
BR112019010949A2 (en) | 2017-01-11 | 2019-10-01 | Ferring Bv | fast disintegrating pharmaceutical composition |
DE102017104472A1 (en) | 2017-03-03 | 2018-09-06 | Nordmark Arzneimittel Gmbh & Co. Kg | Orodispersible tablet containing burlulipase and pharmaceutical composition prepared therefrom |
JP2021518413A (en) | 2018-03-20 | 2021-08-02 | アイカーン スクール オブ メディシン アット マウント サイナイ | Kinase inhibitor compounds and compositions and usage |
CA3124700A1 (en) | 2018-12-31 | 2020-07-09 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
WO2024143501A1 (en) * | 2022-12-28 | 2024-07-04 | 中外製薬株式会社 | Solid dispersion containing substance to be dispersed, pharmaceutical composition containing same, and production methods therefor |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4764378A (en) * | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
CA2070061C (en) * | 1991-06-07 | 2004-02-10 | Shigeyuki Takama | Physiologically active polypeptide-containing pharmaceutical composition |
JP3253127B2 (en) * | 1991-06-07 | 2002-02-04 | 帝國製薬株式会社 | Preparation containing bioactive polypeptide |
US5298256A (en) * | 1992-04-28 | 1994-03-29 | Corint, Ltd. | Desmopressin buccal patch composition |
US5849322A (en) * | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
EP1146800A1 (en) * | 1999-01-27 | 2001-10-24 | Spenco Medical Corporation | Therapeutic magnetic insoles |
GB9901819D0 (en) * | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
US6210699B1 (en) * | 1999-04-01 | 2001-04-03 | Watson Pharmaceuticals, Inc. | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
GB9908014D0 (en) * | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
-
2003
- 2003-05-07 DE DE2003607082 patent/DE60307082T4/en not_active Expired - Lifetime
- 2003-05-07 CA CA002484724A patent/CA2484724C/en not_active Expired - Lifetime
- 2003-05-07 NZ NZ535861A patent/NZ535861A/en not_active IP Right Cessation
- 2003-05-07 PT PT03727870T patent/PT1501534E/en unknown
- 2003-05-07 AU AU2003233118A patent/AU2003233118B8/en not_active Expired
- 2003-05-07 JP JP2004502972A patent/JP2006502972A/en active Pending
- 2003-05-07 BR BR0309819-2A patent/BR0309819A/en not_active Application Discontinuation
- 2003-05-07 DE DE60307082A patent/DE60307082D1/en not_active Expired - Lifetime
- 2003-05-07 WO PCT/IB2003/002368 patent/WO2003094886A2/en active IP Right Grant
-
2004
- 2004-12-03 HR HR20041152A patent/HRP20041152B1/en not_active IP Right Cessation
- 2004-12-06 NO NO20045345A patent/NO335167B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2006502972A (en) | 2006-01-26 |
NO335167B1 (en) | 2014-10-06 |
DE60307082T2 (en) | 2007-01-18 |
AU2003233118A1 (en) | 2003-11-11 |
WO2003094886A2 (en) | 2003-11-20 |
PT1501534E (en) | 2006-09-29 |
BR0309819A (en) | 2005-03-01 |
CA2484724A1 (en) | 2003-11-20 |
WO2003094886A3 (en) | 2004-07-22 |
NO20045345L (en) | 2005-02-07 |
HRP20041152A2 (en) | 2005-04-30 |
DE60307082T4 (en) | 2015-04-30 |
AU2003233118B8 (en) | 2009-07-30 |
HRP20041152B1 (en) | 2008-01-31 |
AU2003233118B2 (en) | 2006-10-26 |
NZ535861A (en) | 2006-11-30 |
CA2484724C (en) | 2007-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60307082D1 (en) | PHARMACEUTICAL COMPOSITION WITH DESMOPRESSIN DISPERSIBLE IN THE MOUTH VALVE | |
DE60304993D1 (en) | DISPERSIBLE PHARMACEUTICAL COMPOSITION WITH AGOMELATIN IN THE MOUTH VALVE | |
PL1919894T3 (en) | Novel polyquinoline derivatives and the therapeutic use thereof | |
EP1824467A4 (en) | Apogossypolone and the uses thereof | |
IL182947A0 (en) | Chimeric polypeptides and pharmaceutical compositions containing the same | |
EP1715882A4 (en) | Smac peptidomimetics and the uses thereof | |
DE502006005914D1 (en) | SEN IN THE BODY'S INSIDE | |
EP1723408A4 (en) | Nanowire light sensor and kit with the same | |
EP1781114A4 (en) | Barrier compositions and articles produced with the compositions | |
ZA200706254B (en) | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same | |
GB2396016B (en) | J-spectroscopy in the wellbore | |
IL186102A0 (en) | Alpha ketoamide derivatives and pharmaceutical compositions containing the same | |
PL394604A1 (en) | Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition | |
AP2005003420A0 (en) | Acidic composition and its uses. | |
BR0301351B1 (en) | Ball valve with flowmeter incorporated directly into the balls. | |
IL181216A0 (en) | 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same | |
DE60310526D1 (en) | IVABRADINE-CONTAINING PHARMACEUTICAL COMPOSITION WITH ORAL DISPERSION | |
FI20011074A (en) | Foundation in the watershed | |
HK1075272A1 (en) | Dye composition and the use thereof | |
HK1073664A1 (en) | Dye compositions and the use thereof | |
DE60305642D1 (en) | DISPERSIBLE PHARMACEUTICAL COMPOSITION WITH PIRIBEDIL IN THE MOUTH VALVE | |
GB0312340D0 (en) | Improved game and aricle for use with the game | |
GB0323138D0 (en) | Pyrimidines substituted in the 2,4,6 positions and their different uses | |
ITTO20060204A1 (en) | COLLECTORS, IN PARTICULAR, STACKABLE AND INSERTABLE THE ONE INSIDE THE OTHER | |
FI20045309A (en) | Method and arrangement in the coating line |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |